中国医学科学院学报

高级检索
中国医学科学院学报

中国医学科学院学报 ›› 2020, Vol. 42 ›› Issue (2): 263-269.doi: 10.3881/j.issn.1000-503X.11226

• 综述 • 上一篇    下一篇

膀胱癌盆腔淋巴结清扫的研究进展

王飞,秦彩朋,杨文博,刘士军(),徐涛   

  1. 北京大学人民医院泌尿外科,北京 100032
  • 收稿日期:2019-02-01 出版日期:2020-04-28 发布日期:2020-05-07
  • 通讯作者: 刘士军 E-mail:liushijun1206@sina.com
  • 基金资助:
    北京大学人民医院研究与发展基金(RDX2018-03)

Advances in Pelvic Lymph Node Dissection for Bladder Cancer

WANG Fei,QIN Caipeng,YANG Wenbo,LIU Shijun(),XU Tao   

  1. Department of Urinary Surgery,Peking University People’s Hospital,Beijing 100032,China
  • Received:2019-02-01 Online:2020-04-28 Published:2020-05-07
  • Contact: LIU Shijun E-mail:liushijun1206@sina.com
  • Supported by:
    Supported by the Research and Development Foundation of the Peking University People’s Hospital(RDX2018-03)

摘要:

膀胱癌的发病率居高不下,是威胁全世界人类生命的主要肿瘤之一,其在西方国家发病率较高,在我国的发病也逐年增长,根治性膀胱全切术联合盆腔淋巴结清扫(PLND)是治疗膀胱癌的标准治疗术式,但PLND的最佳清扫范围仍是争论的热点问题,相关的淋巴结因素的预后意义也说法不一,本文通过回顾相关文献,对PLND相关研究进行综述。

关键词: 膀胱癌, 盆腔淋巴结清扫, 预后

Abstract:

Bladder cancer has high morbidity and mortality rates worldwide. Its incidence is high in western countries and has shown an increasing trend in China. While radical cystectomy combined with pelvic lymph node dissection (PLND) is the standard treatment for bladder cancer,the optimal range of PLND remains controversial. In addition,the prognostic value of lymph node factors is also unclear. This article reviews research advances in PLND.

Key words: bladder cancer, pelvic lymph node dissection, prognosis

中图分类号: